Drugs for Gastrointestinal Diseases — MCQs

Q: Which of the following drugs is NOT effective against chemotherapy-induced vomiting?

Hyoscine. **Explanation:** The correct answer is **Hyoscine (Scopolamine)**. **1. Why Hyoscine is the correct answer:** Chemotherapy-induced nausea and vomiting (CINV) is primarily mediated by the stimulation of the **Chemoreceptor Trigger Zone (CTZ)** and the release of neurotransmitters like serotonin, substance P, and dopamine in the gut and brainstem. **Hyoscine** is an anticholinergic drug that acts primarily on the **vestibular system** (M1 receptors). It is highly effective for **motion sickness** but has no significant efficacy against the chemical triggers involved in CINV. **2. Why the other options are incorrect:** * **Aprepitant:** This is a **Neurokinin-1 (NK1) receptor antagonist**. It blocks the action of Substance P and is specifically indicated for the prevention of both acute and delayed phases of highly emetogenic chemotherapy. * **Metoclopramide:** A **D2 receptor antagonist** that also has 5-HT3 antagonistic properties at higher doses. It acts on the CTZ and enhances gastric emptying (prokinetic), making it useful in CINV. * **Ondansetron:** A **5-HT3 receptor antagonist**. It is the "gold standard" and first-line treatment for preventing acute emesis caused by chemotherapy by blocking serotonin receptors on vagal afferents and the CTZ. **Clinical Pearls for NEET-PG:** * **Drug of choice for Motion Sickness:** Hyoscine (administered as a transdermal patch behind the ear). * **Drug of choice for CINV:** 5-HT3 antagonists (e.g., Ondansetron). * **Drug of choice for Morning Sickness (Pregnancy):** Doxylamine + Pyridoxine. * **Drug of choice for Post-operative vomiting:** Ondansetron. * **Steroid use in CINV:** Dexamethasone is often added to Ondansetron/Aprepitant to potentiate their anti-emetic effects.

Q: Which of the following drugs cause relaxation of the lower esophageal sphincter (LES)?

Nitrates, Atropine, and Calcium channel blockers. ### Explanation The tone of the lower esophageal sphincter (LES) is regulated by a complex interplay of myogenic, neural, and hormonal factors. Relaxation of the LES is a critical pharmacological concept because it can both cause Gastroesophageal Reflux Disease (GERD) as a side effect and be used therapeutically to treat conditions like Achalasia Cardia. **Why Option B is Correct:** * **Nitrates:** These act as nitric oxide (NO) donors. NO is the primary inhibitory neurotransmitter in the esophagus, leading to smooth muscle relaxation via the cGMP pathway. * **Atropine:** As an anticholinergic (muscarinic antagonist), it blocks the excitatory effect of acetylcholine on the LES, thereby reducing resting pressure. * **Calcium Channel Blockers (CCBs):** Drugs like Nifedipine inhibit the entry of calcium into smooth muscle cells, which is essential for muscle contraction, leading to significant LES relaxation. **Analysis of Incorrect Options:** * **Histamine Blockers (H2 Blockers):** Drugs like Ranitidine primarily decrease gastric acid secretion. They do not significantly decrease LES tone; in fact, they are used to *treat* the symptoms caused by a relaxed LES (GERD). * **Morphine:** Opioids generally increase the tone of various sphincters in the GI tract (e.g., Sphincter of Oddi) and do not typically cause LES relaxation as a primary mechanism. **High-Yield Clinical Pearls for NEET-PG:** * **Achalasia Cardia:** CCBs and Nitrates are used for medical management to decrease LES pressure, though pneumatic dilation or Myotomy are preferred. * **Drugs that INCREASE LES Tone:** Metoclopramide, Domperidone (Prokinetics), and Cholinergic agonists (Bethanechol). * **Lifestyle Factors:** Caffeine, fatty meals, chocolate, and smoking also decrease LES tone and should be avoided in GERD patients.

Q: Alosetron is:

A 5HT3 receptor antagonist. ### Explanation **Correct Option: C (A 5HT3 receptor antagonist)** **Mechanism of Action:** Alosetron is a potent and selective **5-HT3 receptor antagonist**. In the gastrointestinal tract, 5-HT3 receptors are located on enteric neurons and are responsible for regulating visceral pain, colonic transit, and gastrointestinal secretions. By blocking these receptors, Alosetron reduces abdominal pain, decreases intestinal secretions, and slows colonic transit time, making it effective for managing diarrhea-predominant symptoms. **Analysis of Incorrect Options:** * **Option A (5HT1 antagonist):** 5-HT1 receptors (specifically 5-HT1B/1D) are targets for Triptans (agonists) used in migraine. There is no major clinical role for 5-HT1 antagonists in GI disorders. * **Option B (5HT2 antagonist):** Drugs like Cyproheptadine block 5-HT2 receptors and are used for serotonin syndrome or as appetite stimulants, but they do not share Alosetron's clinical profile for IBS. * **Option D (Somatostatin analogues):** This refers to drugs like **Octreotide**, used for secretory diarrheas (e.g., VIPoma, Carcinoid syndrome) and variceal bleeding, not Alosetron. **High-Yield Clinical Pearls for NEET-PG:** * **Indication:** Specifically approved for **severe, diarrhea-predominant Irritable Bowel Syndrome (IBS-D) in women** who have not responded to conventional therapy. * **Black Box Warning:** It is associated with a rare but serious risk of **Ischemic Colitis** and severe constipation. Due to these risks, it is often prescribed under a restricted safety program. * **Comparison:** While Alosetron (antagonist) is for IBS-D, **Prucalopride** (5-HT4 agonist) is used for chronic constipation.

Q: Doxylamine, used in the management of nausea and vomiting, is marketed with which vitamin?

Pyridoxine. **Explanation:** The combination of **Doxylamine and Pyridoxine (Vitamin B6)** is the first-line pharmacological treatment for **Nausea and Vomiting of Pregnancy (NVP)**, commonly known as morning sickness, when conservative management fails. * **Doxylamine** is a first-generation H1-receptor antagonist with potent antihistaminic and anticholinergic properties that act on the vestibular system and the Chemoreceptor Trigger Zone (CTZ) to reduce nausea. * **Pyridoxine (Vitamin B6)** is a water-soluble vitamin involved in amino acid metabolism. While its exact mechanism in NVP is not fully understood, clinical trials have demonstrated that it significantly reduces the severity of nausea. **Analysis of Incorrect Options:** * **A. Thiamine (B1):** Deficiency causes Wernicke-Korsakoff syndrome and Beriberi. It is not used for anti-emetic purposes. * **B. Riboflavin (B2):** Primarily used for migraine prophylaxis and treating ariboflavinosis (cheilosis, glossitis). * **C. Niacin (B3):** Used in the treatment of Pellagra and hyperlipidemia; it can actually cause GI upset and flushing as side effects. **High-Yield Clinical Pearls for NEET-PG:** * **FDA Category:** This combination (formerly marketed as *Diclegis* or *Bendectin*) is one of the few drugs with an **FDA Category A** rating for use in pregnancy, indicating no evidence of fetal risk. * **Mechanism:** Doxylamine crosses the blood-brain barrier (hence its sedative effect), while Pyridoxine may enhance the synthesis of GABA or serotonin, potentially modulating the emetic reflex. * **Second-line agents:** If this combination fails, other drugs like Metoclopramide, Promethazine, or Ondansetron (used with caution in the first trimester) may be considered.

Q: Which of the following is NOT an effective medical therapy for variceal bleeding in the setting of cirrhosis of the liver?

Omeprazole. **Explanation:** The management of acute variceal bleeding focuses on reducing **portal venous pressure** to stop the hemorrhage. **Why Omeprazole is the correct answer:** Omeprazole is a Proton Pump Inhibitor (PPI) that reduces gastric acid secretion. While PPIs are the gold standard for treating **peptic ulcer bleeding**, they have no effect on portal hemodynamics or splanchnic blood flow. Therefore, they are **not effective** in stopping or preventing variceal bleeding, which is a mechanical result of portal hypertension rather than acid-peptic injury. **Why the other options are incorrect:** * **Terlipressin:** A synthetic analogue of vasopressin. it is the **drug of choice** for acute variceal bleeds. It acts on $V_1$ receptors to cause potent splanchnic vasoconstriction, thereby reducing portal pressure. It is the only drug proven to reduce mortality in these patients. * **Somatostatin & Octreotide:** These agents cause selective splanchnic vasoconstriction by inhibiting the release of vasodilator hormones like glucagon. They are highly effective and have fewer side effects compared to non-selective vasopressin. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (Acute Bleed):** Terlipressin (most effective for mortality benefit). * **Drug of Choice (Prophylaxis):** Non-selective beta-blockers (e.g., **Propranolol, Nadolol**) are used for primary and secondary prophylaxis as they reduce portal flow via $\beta_2$ blockade (splanchnic vasoconstriction) and $\beta_1$ blockade (reduced cardiac output). * **Definitive Management:** Endoscopic Variceal Ligation (EVL) is the preferred procedural intervention. * **Antibiotic Prophylaxis:** Always administer (e.g., Ceftriaxone) to cirrhotic patients with GI bleeds to prevent spontaneous bacterial peritonitis (SBP).

Q: Which one of the following drugs is useful in the treatment of gastroesophageal reflux disease?

Metoclopramide. **Explanation:** **Metoclopramide** is the correct answer because it is a **prokinetic agent**. In Gastroesophageal Reflux Disease (GERD), the primary goals are to increase the Lower Esophageal Sphincter (LES) tone and accelerate gastric emptying. Metoclopramide achieves this through dual mechanisms: 1. **D2 receptor antagonism:** Blocks dopamine-mediated inhibition of cholinergic activity in the GI tract. 2. **5-HT4 receptor agonism:** Stimulates the release of Acetylcholine from the myenteric plexus. This results in increased LES pressure (preventing reflux) and enhanced gastric motility (reducing the volume of acid available to reflux). **Analysis of Incorrect Options:** * **Atropine:** An anticholinergic drug that decreases GI motility and relaxes the LES. This would worsen GERD by allowing more acid to reflux and stay in the esophagus longer. * **Ondansetron:** A selective 5-HT3 receptor antagonist used primarily as an antiemetic (especially for chemotherapy-induced nausea). It has no significant effect on GI motility or LES tone. * **Sodium Citrate:** A non-particulate systemic antacid used to neutralize gastric pH before emergency surgery (Mendelson’s syndrome). While it neutralizes acid, it is not a primary treatment for chronic GERD. **Clinical Pearls for NEET-PG:** * **Side Effects:** Metoclopramide can cross the Blood-Brain Barrier, leading to **Extrapyramidal Symptoms (EPS)** like acute dystonia and parkinsonism due to D2 blockade in the basal ganglia. * **Drug of Choice:** While prokinetics help, **Proton Pump Inhibitors (PPIs)** like Omeprazole remain the "Gold Standard" for GERD treatment. * **Domperidone:** A similar prokinetic that does *not* cross the BBB, thus having a lower risk of EPS compared to Metoclopramide.

Q: Which of the following agents are useful in the medical treatment of variceal bleeding?

Octreotide. **Explanation:** The management of acute variceal bleeding focuses on achieving hemodynamic stability and reducing portal venous pressure. **1. Why Octreotide is Correct:** **Octreotide** is a synthetic long-acting analogue of **Somatostatin**. It is the drug of choice for acute variceal hemorrhage. It works by causing **selective splanchnic vasoconstriction**, which reduces portal blood flow and decreases portal venous pressure without the systemic side effects seen with Vasopressin. It also inhibits the release of glucagon, a potent vasodilator of the splanchnic circulation. **2. Why the other options are incorrect:** * **Pantoprazole:** This is a Proton Pump Inhibitor (PPI). While PPIs are essential for treating peptic ulcer disease and preventing stress ulcers, they do not reduce portal pressure and have no direct role in stopping active variceal bleeding. * **Somatotropin:** This is a recombinant Growth Hormone used for growth failure and Turner syndrome. It has no role in hemodynamic management or portal hypertension. * **Dexamethasone:** This is a potent corticosteroid used for its anti-inflammatory and immunosuppressive effects. It is not indicated in the management of variceal bleeding. **3. NEET-PG High-Yield Pearls:** * **Terlipressin:** A synthetic analogue of Vasopressin; it is the only drug shown to **improve survival** in acute variceal bleeding. It has a longer half-life and fewer cardiac side effects than Vasopressin. * **Prophylaxis:** Non-selective beta-blockers (e.g., **Propranolol, Nadolol**) are used for the *primary prevention* of variceal bleeding, but they are **contraindicated** during an acute bleeding episode. * **Antibiotics:** Prophylactic antibiotics (e.g., Ceftriaxone) are mandatory in cirrhotic patients with variceal bleeding to prevent spontaneous bacterial peritonitis (SBP).

Q: Which of the following drugs is used for Irritable Bowel Syndrome of the constipating type?

Lubiprostone. **Explanation:** **Lubiprostone** is a bicyclic fatty acid derivative that acts as a selective **Type-2 Chloride Channel (ClC-2) activator** in the apical membrane of the intestinal epithelium. By stimulating these channels, it increases the secretion of chloride-rich intestinal fluid, which in turn softens the stool and accelerates intestinal transit. It is FDA-approved for **Irritable Bowel Syndrome with Constipation (IBS-C)** in women and for chronic idiopathic constipation. **Analysis of Incorrect Options:** * **Cholestyramine (Option B):** This is a bile acid sequestrant used for **IBS with Diarrhea (IBS-D)**. It binds to bile acids in the lumen, preventing them from causing secretory diarrhea in patients with bile acid malabsorption. * **Alosetron (Option C):** A potent **5-HT3 receptor antagonist**. It reduces intestinal motility and is used exclusively for severe **IBS-D** in women. It is associated with a risk of ischemic colitis. * **Rifaximin (Option D):** A non-absorbable antibiotic used for **IBS without constipation** (IBS-D or mixed type). It works by altering the gut microbiota and reducing gas production. **High-Yield NEET-PG Pearls:** * **Linaclotide & Plecanatide:** Other drugs for IBS-C; they act as **Guanylate Cyclase-C (GC-C) agonists**, increasing cGMP and stimulating the CFTR channel. * **Tegaserod:** A 5-HT4 partial agonist used for IBS-C, though its use is restricted due to cardiovascular side effects. * **Eluxadoline:** A mu-opioid receptor agonist used for IBS-D. * **Lubiprostone Side Effect:** Nausea is the most common adverse effect (mitigated by taking it with food).

Drugs for Gastrointestinal Diseases — MCQs

Drugs for Gastrointestinal Diseases Indian Medical PG Practice Questions and MCQs

Question 1: Which of the following drugs is NOT effective against chemotherapy-induced vomiting?

A. Aprepitant
B. Hyoscine (Correct Answer)
C. Metoclopramide
D. Ondansetron

Explanation: **Explanation:** The correct answer is **Hyoscine (Scopolamine)**. **1. Why Hyoscine is the correct answer:** Chemotherapy-induced nausea and vomiting (CINV) is primarily mediated by the stimulation of the **Chemoreceptor Trigger Zone (CTZ)** and the release of neurotransmitters like serotonin, substance P, and dopamine in the gut and brainstem. **Hyoscine** is an anticholinergic drug that acts primarily on the **vestibular system** (M1 receptors). It is highly effective for **motion sickness** but has no significant efficacy against the chemical triggers involved in CINV. **2. Why the other options are incorrect:** * **Aprepitant:** This is a **Neurokinin-1 (NK1) receptor antagonist**. It blocks the action of Substance P and is specifically indicated for the prevention of both acute and delayed phases of highly emetogenic chemotherapy. * **Metoclopramide:** A **D2 receptor antagonist** that also has 5-HT3 antagonistic properties at higher doses. It acts on the CTZ and enhances gastric emptying (prokinetic), making it useful in CINV. * **Ondansetron:** A **5-HT3 receptor antagonist**. It is the "gold standard" and first-line treatment for preventing acute emesis caused by chemotherapy by blocking serotonin receptors on vagal afferents and the CTZ. **Clinical Pearls for NEET-PG:** * **Drug of choice for Motion Sickness:** Hyoscine (administered as a transdermal patch behind the ear). * **Drug of choice for CINV:** 5-HT3 antagonists (e.g., Ondansetron). * **Drug of choice for Morning Sickness (Pregnancy):** Doxylamine + Pyridoxine. * **Drug of choice for Post-operative vomiting:** Ondansetron. * **Steroid use in CINV:** Dexamethasone is often added to Ondansetron/Aprepitant to potentiate their anti-emetic effects.

Question 2: Which of the following drugs cause relaxation of the lower esophageal sphincter (LES)?

A. Nitrates, Histamine blockers, and Morphine
B. Nitrates, Atropine, and Calcium channel blockers (Correct Answer)
C. Nitrates, Histamine blockers, and Calcium channel blockers
D. All of the above

Explanation: ### Explanation The tone of the lower esophageal sphincter (LES) is regulated by a complex interplay of myogenic, neural, and hormonal factors. Relaxation of the LES is a critical pharmacological concept because it can both cause Gastroesophageal Reflux Disease (GERD) as a side effect and be used therapeutically to treat conditions like Achalasia Cardia. **Why Option B is Correct:** * **Nitrates:** These act as nitric oxide (NO) donors. NO is the primary inhibitory neurotransmitter in the esophagus, leading to smooth muscle relaxation via the cGMP pathway. * **Atropine:** As an anticholinergic (muscarinic antagonist), it blocks the excitatory effect of acetylcholine on the LES, thereby reducing resting pressure. * **Calcium Channel Blockers (CCBs):** Drugs like Nifedipine inhibit the entry of calcium into smooth muscle cells, which is essential for muscle contraction, leading to significant LES relaxation. **Analysis of Incorrect Options:** * **Histamine Blockers (H2 Blockers):** Drugs like Ranitidine primarily decrease gastric acid secretion. They do not significantly decrease LES tone; in fact, they are used to *treat* the symptoms caused by a relaxed LES (GERD). * **Morphine:** Opioids generally increase the tone of various sphincters in the GI tract (e.g., Sphincter of Oddi) and do not typically cause LES relaxation as a primary mechanism. **High-Yield Clinical Pearls for NEET-PG:** * **Achalasia Cardia:** CCBs and Nitrates are used for medical management to decrease LES pressure, though pneumatic dilation or Myotomy are preferred. * **Drugs that INCREASE LES Tone:** Metoclopramide, Domperidone (Prokinetics), and Cholinergic agonists (Bethanechol). * **Lifestyle Factors:** Caffeine, fatty meals, chocolate, and smoking also decrease LES tone and should be avoided in GERD patients.

Question 3: Alosetron is:

A. A 5HT1 receptor antagonist
B. A 5HT2 receptor antagonist
C. A 5HT3 receptor antagonist (Correct Answer)
D. Analogues of somatostatin

Explanation: ### Explanation **Correct Option: C (A 5HT3 receptor antagonist)** **Mechanism of Action:** Alosetron is a potent and selective **5-HT3 receptor antagonist**. In the gastrointestinal tract, 5-HT3 receptors are located on enteric neurons and are responsible for regulating visceral pain, colonic transit, and gastrointestinal secretions. By blocking these receptors, Alosetron reduces abdominal pain, decreases intestinal secretions, and slows colonic transit time, making it effective for managing diarrhea-predominant symptoms. **Analysis of Incorrect Options:** * **Option A (5HT1 antagonist):** 5-HT1 receptors (specifically 5-HT1B/1D) are targets for Triptans (agonists) used in migraine. There is no major clinical role for 5-HT1 antagonists in GI disorders. * **Option B (5HT2 antagonist):** Drugs like Cyproheptadine block 5-HT2 receptors and are used for serotonin syndrome or as appetite stimulants, but they do not share Alosetron's clinical profile for IBS. * **Option D (Somatostatin analogues):** This refers to drugs like **Octreotide**, used for secretory diarrheas (e.g., VIPoma, Carcinoid syndrome) and variceal bleeding, not Alosetron. **High-Yield Clinical Pearls for NEET-PG:** * **Indication:** Specifically approved for **severe, diarrhea-predominant Irritable Bowel Syndrome (IBS-D) in women** who have not responded to conventional therapy. * **Black Box Warning:** It is associated with a rare but serious risk of **Ischemic Colitis** and severe constipation. Due to these risks, it is often prescribed under a restricted safety program. * **Comparison:** While Alosetron (antagonist) is for IBS-D, **Prucalopride** (5-HT4 agonist) is used for chronic constipation.

Question 4: All the drugs given below can be used to protect gastric ulcer except?

A. Colloidal bismuth salt
B. Magnesium hydroxide (Correct Answer)
C. Misoprostal
D. Sucralfate

Explanation: ### Explanation The question asks to identify the drug that does **not** act as a "gastric mucosal protectant." **1. Why Magnesium Hydroxide is the Correct Answer:** Magnesium hydroxide is a **systemic/non-systemic antacid**. Its primary mechanism is the chemical neutralization of gastric hydrochloric acid (HCl), thereby increasing the gastric pH. While it reduces the aggressive factor (acid), it does not form a physical protective barrier over the ulcer base or enhance mucosal defense mechanisms. Therefore, it is classified as an antacid, not a mucosal protectant. **2. Why the other options are incorrect (Mucosal Protectants):** * **Sucralfate:** An aluminum salt of sulfated sucrose. In an acidic medium (pH < 4), it polymerizes into a sticky paste that binds selectively to the ulcer base (proteins/exudates), forming a physical barrier against acid and pepsin. * **Colloidal Bismuth Subcitrate (CBS):** It precipitates at low pH, coats the ulcer base, and detaches *H. pylori* from the gastric epithelium. It also stimulates prostaglandin synthesis and mucus/bicarbonate secretion. * **Misoprostol:** A PGE1 analogue. It acts as a cytoprotective agent by increasing mucus and bicarbonate secretion and improving mucosal blood flow. It also inhibits acid secretion via EP3 receptors on parietal cells. **3. NEET-PG High-Yield Pearls:** * **Sucralfate:** Requires an acidic medium for activation; hence, it should **not** be given with antacids, H2 blockers, or PPIs. * **Misoprostol:** Drug of choice for **NSAID-induced gastric ulcers** in patients who must continue NSAIDs. It is contraindicated in pregnancy (abortifacient). * **Bismuth salts:** Can cause black discoloration of stools and tongue (harmless) and are a component of Bismuth-based quadruple therapy for *H. pylori*. * **Antacid Side Effects:** Magnesium salts cause **diarrhea** ("Mg = Must Go"), while Aluminum salts cause **constipation**. They are often combined to balance bowel effects.

Question 5: Doxylamine, used in the management of nausea and vomiting, is marketed with which vitamin?

A. Thiamine
B. Riboflavin
C. Niacin
D. Pyridoxine (Correct Answer)

Explanation: **Explanation:** The combination of **Doxylamine and Pyridoxine (Vitamin B6)** is the first-line pharmacological treatment for **Nausea and Vomiting of Pregnancy (NVP)**, commonly known as morning sickness, when conservative management fails. * **Doxylamine** is a first-generation H1-receptor antagonist with potent antihistaminic and anticholinergic properties that act on the vestibular system and the Chemoreceptor Trigger Zone (CTZ) to reduce nausea. * **Pyridoxine (Vitamin B6)** is a water-soluble vitamin involved in amino acid metabolism. While its exact mechanism in NVP is not fully understood, clinical trials have demonstrated that it significantly reduces the severity of nausea. **Analysis of Incorrect Options:** * **A. Thiamine (B1):** Deficiency causes Wernicke-Korsakoff syndrome and Beriberi. It is not used for anti-emetic purposes. * **B. Riboflavin (B2):** Primarily used for migraine prophylaxis and treating ariboflavinosis (cheilosis, glossitis). * **C. Niacin (B3):** Used in the treatment of Pellagra and hyperlipidemia; it can actually cause GI upset and flushing as side effects. **High-Yield Clinical Pearls for NEET-PG:** * **FDA Category:** This combination (formerly marketed as *Diclegis* or *Bendectin*) is one of the few drugs with an **FDA Category A** rating for use in pregnancy, indicating no evidence of fetal risk. * **Mechanism:** Doxylamine crosses the blood-brain barrier (hence its sedative effect), while Pyridoxine may enhance the synthesis of GABA or serotonin, potentially modulating the emetic reflex. * **Second-line agents:** If this combination fails, other drugs like Metoclopramide, Promethazine, or Ondansetron (used with caution in the first trimester) may be considered.

Question 6: Which of the following is NOT an effective medical therapy for variceal bleeding in the setting of cirrhosis of the liver?

A. Somatostatin
B. Octreotide
C. Terlipressin
D. Omeprazole (Correct Answer)

Explanation: **Explanation:** The management of acute variceal bleeding focuses on reducing **portal venous pressure** to stop the hemorrhage. **Why Omeprazole is the correct answer:** Omeprazole is a Proton Pump Inhibitor (PPI) that reduces gastric acid secretion. While PPIs are the gold standard for treating **peptic ulcer bleeding**, they have no effect on portal hemodynamics or splanchnic blood flow. Therefore, they are **not effective** in stopping or preventing variceal bleeding, which is a mechanical result of portal hypertension rather than acid-peptic injury. **Why the other options are incorrect:** * **Terlipressin:** A synthetic analogue of vasopressin. it is the **drug of choice** for acute variceal bleeds. It acts on $V_1$ receptors to cause potent splanchnic vasoconstriction, thereby reducing portal pressure. It is the only drug proven to reduce mortality in these patients. * **Somatostatin & Octreotide:** These agents cause selective splanchnic vasoconstriction by inhibiting the release of vasodilator hormones like glucagon. They are highly effective and have fewer side effects compared to non-selective vasopressin. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (Acute Bleed):** Terlipressin (most effective for mortality benefit). * **Drug of Choice (Prophylaxis):** Non-selective beta-blockers (e.g., **Propranolol, Nadolol**) are used for primary and secondary prophylaxis as they reduce portal flow via $\beta_2$ blockade (splanchnic vasoconstriction) and $\beta_1$ blockade (reduced cardiac output). * **Definitive Management:** Endoscopic Variceal Ligation (EVL) is the preferred procedural intervention. * **Antibiotic Prophylaxis:** Always administer (e.g., Ceftriaxone) to cirrhotic patients with GI bleeds to prevent spontaneous bacterial peritonitis (SBP).

Question 7: Which one of the following drugs is useful in the treatment of gastroesophageal reflux disease?

A. Atropine
B. Ondansetron
C. Metoclopramide (Correct Answer)
D. Sodium citrate

Explanation: **Explanation:** **Metoclopramide** is the correct answer because it is a **prokinetic agent**. In Gastroesophageal Reflux Disease (GERD), the primary goals are to increase the Lower Esophageal Sphincter (LES) tone and accelerate gastric emptying. Metoclopramide achieves this through dual mechanisms: 1. **D2 receptor antagonism:** Blocks dopamine-mediated inhibition of cholinergic activity in the GI tract. 2. **5-HT4 receptor agonism:** Stimulates the release of Acetylcholine from the myenteric plexus. This results in increased LES pressure (preventing reflux) and enhanced gastric motility (reducing the volume of acid available to reflux). **Analysis of Incorrect Options:** * **Atropine:** An anticholinergic drug that decreases GI motility and relaxes the LES. This would worsen GERD by allowing more acid to reflux and stay in the esophagus longer. * **Ondansetron:** A selective 5-HT3 receptor antagonist used primarily as an antiemetic (especially for chemotherapy-induced nausea). It has no significant effect on GI motility or LES tone. * **Sodium Citrate:** A non-particulate systemic antacid used to neutralize gastric pH before emergency surgery (Mendelson’s syndrome). While it neutralizes acid, it is not a primary treatment for chronic GERD. **Clinical Pearls for NEET-PG:** * **Side Effects:** Metoclopramide can cross the Blood-Brain Barrier, leading to **Extrapyramidal Symptoms (EPS)** like acute dystonia and parkinsonism due to D2 blockade in the basal ganglia. * **Drug of Choice:** While prokinetics help, **Proton Pump Inhibitors (PPIs)** like Omeprazole remain the "Gold Standard" for GERD treatment. * **Domperidone:** A similar prokinetic that does *not* cross the BBB, thus having a lower risk of EPS compared to Metoclopramide.

Question 8: Which of the following agents are useful in the medical treatment of variceal bleeding?

A. Octreotide (Correct Answer)
B. Pantoprazole
C. Somatotropin
D. Dexamethasone

Explanation: **Explanation:** The management of acute variceal bleeding focuses on achieving hemodynamic stability and reducing portal venous pressure. **1. Why Octreotide is Correct:** **Octreotide** is a synthetic long-acting analogue of **Somatostatin**. It is the drug of choice for acute variceal hemorrhage. It works by causing **selective splanchnic vasoconstriction**, which reduces portal blood flow and decreases portal venous pressure without the systemic side effects seen with Vasopressin. It also inhibits the release of glucagon, a potent vasodilator of the splanchnic circulation. **2. Why the other options are incorrect:** * **Pantoprazole:** This is a Proton Pump Inhibitor (PPI). While PPIs are essential for treating peptic ulcer disease and preventing stress ulcers, they do not reduce portal pressure and have no direct role in stopping active variceal bleeding. * **Somatotropin:** This is a recombinant Growth Hormone used for growth failure and Turner syndrome. It has no role in hemodynamic management or portal hypertension. * **Dexamethasone:** This is a potent corticosteroid used for its anti-inflammatory and immunosuppressive effects. It is not indicated in the management of variceal bleeding. **3. NEET-PG High-Yield Pearls:** * **Terlipressin:** A synthetic analogue of Vasopressin; it is the only drug shown to **improve survival** in acute variceal bleeding. It has a longer half-life and fewer cardiac side effects than Vasopressin. * **Prophylaxis:** Non-selective beta-blockers (e.g., **Propranolol, Nadolol**) are used for the *primary prevention* of variceal bleeding, but they are **contraindicated** during an acute bleeding episode. * **Antibiotics:** Prophylactic antibiotics (e.g., Ceftriaxone) are mandatory in cirrhotic patients with variceal bleeding to prevent spontaneous bacterial peritonitis (SBP).

Question 9: Which of the following drugs is used for Irritable Bowel Syndrome of the constipating type?

A. Lubiprostone (Correct Answer)
B. Cholestyramine
C. Alosetron
D. Rifaximin

Explanation: **Explanation:** **Lubiprostone** is a bicyclic fatty acid derivative that acts as a selective **Type-2 Chloride Channel (ClC-2) activator** in the apical membrane of the intestinal epithelium. By stimulating these channels, it increases the secretion of chloride-rich intestinal fluid, which in turn softens the stool and accelerates intestinal transit. It is FDA-approved for **Irritable Bowel Syndrome with Constipation (IBS-C)** in women and for chronic idiopathic constipation. **Analysis of Incorrect Options:** * **Cholestyramine (Option B):** This is a bile acid sequestrant used for **IBS with Diarrhea (IBS-D)**. It binds to bile acids in the lumen, preventing them from causing secretory diarrhea in patients with bile acid malabsorption. * **Alosetron (Option C):** A potent **5-HT3 receptor antagonist**. It reduces intestinal motility and is used exclusively for severe **IBS-D** in women. It is associated with a risk of ischemic colitis. * **Rifaximin (Option D):** A non-absorbable antibiotic used for **IBS without constipation** (IBS-D or mixed type). It works by altering the gut microbiota and reducing gas production. **High-Yield NEET-PG Pearls:** * **Linaclotide & Plecanatide:** Other drugs for IBS-C; they act as **Guanylate Cyclase-C (GC-C) agonists**, increasing cGMP and stimulating the CFTR channel. * **Tegaserod:** A 5-HT4 partial agonist used for IBS-C, though its use is restricted due to cardiovascular side effects. * **Eluxadoline:** A mu-opioid receptor agonist used for IBS-D. * **Lubiprostone Side Effect:** Nausea is the most common adverse effect (mitigated by taking it with food).

Question 10: Which group of drugs is most effective for the healing of Non-Steroidal Anti-Inflammatory Drug (NSAID) induced gastric ulcer?

A. Prostaglandin analogues
B. H2-receptor antagonists
C. Proton pump inhibitors (Correct Answer)
D. Antacids

Explanation: <h3>Explanation</h3> 1. Why Proton Pump Inhibitors (PPIs) are the Correct Answer: PPIs (e.g., Omeprazole, Pantoprazole) are the drugs of choice for both the treatment and prevention of NSAID-induced gastric ulcers [3]. NSAIDs cause ulcers by inhibiting COX-1, leading to decreased prostaglandin synthesis, which reduces bicarbonate/mucus secretion and increases acid production [1, 2]. PPIs provide superior and rapid healing because they achieve profound, 24-hour inhibition of the "final common pathway" of acid secretion (the H+/K+ ATPase pump) [1]. Clinical studies consistently show that PPIs heal ulcers faster and more effectively than H2 blockers or Misoprostol, even if the patient continues NSAID therapy [3]. 2. Analysis of Incorrect Options: * Prostaglandin Analogues (Misoprostol): While Misoprostol is specifically effective at replacing the prostaglandins lost due to NSAID use, it is limited by significant side effects (diarrhea, abdominal cramps) and a frequent dosing schedule. It is considered a second-line alternative to PPIs. * H2-Receptor Antagonists (Ranitidine): These are less effective than PPIs in healing gastric ulcers, especially those caused by NSAIDs. They primarily suppress nocturnal acid but are less potent at inhibiting meal-stimulated acid secretion. * Antacids: These provide only symptomatic relief by neutralizing existing gastric acid. They do not promote significant ulcer healing or provide protection against further NSAID damage. 3. NEET-PG High-Yield Pearls: * Drug of Choice for Prevention: PPIs are also the preferred agents for prophylaxis in high-risk patients (e.g., elderly, history of peptic ulcer) taking long-term NSAIDs [3]. * Misoprostol Contraindication: Always remember that Misoprostol is contraindicated in pregnancy due to its oxytocic (uterine contraction) properties, which can cause abortion. * H. pylori status: In patients with NSAID-induced ulcers, it is crucial to test for and treat H. pylori infection, as it acts synergistically with NSAIDs to increase ulcer risk [2].

Practice by Chapter

Acid-Peptic Disease Therapeutics

Practice Questions

Proton Pump Inhibitors

Practice Questions

H2 Receptor Antagonists

Practice Questions

Antacids and Mucosal Protectants

Practice Questions

Antiemetics

Practice Questions

Prokinetic Agents

Practice Questions

Laxatives and Purging Agents

Practice Questions

Antidiarrheal Drugs

Practice Questions

Drugs for Inflammatory Bowel Disease

Practice Questions

Pancreatic Enzyme Supplements

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free